Pathophysiology, therapeutic targets, and future therapeutic alternatives in copd: focus on the importance of the cholinergic system

HIGHLIGHTS

• who: Felisbela Gomes and Shih-Lung Cheng from the Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan Department of Chemical Engineering and Materials Science, Yuan-Ze University, Taoyuan, Taiwan have published the research work: Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System, in the Journal: Biomolecules 2023, 13, x FOR PEER REVIEW of /2023/
• what: Although preclinical studies have shown strategies targeting nicotinic receptors, particularly u03b17, to be promising, this approach has not yet been translated into clinical trials . In this review . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.